Navigation Links
Spit Test Kit on the Cards to Ascertain Pre-eclampsia Risk

A relatively easy and reliable test is on the cards for pregnant women that promises to iron out life threatening risks to expectant mothers and their babies.

Pre-eclampsia, an otherwise lethal pregnancy complication which could kill hundreds of fetuses a year can be averted with a simple saliva test. One in ten pregnancies is fraught with such risks and one in fifty, suffers a virulent repercussion of pre-eclampsia.

This test in its development phase in the United Kingdom, addresses the risks of pre-eclampsia in the initial stages itself so that repercussions on the health of both the mother and the baby can be averted. This test may not offer any cure for the condition apart from monitoring the health problems of expectant mothers and their unborn babies.

Pre-eclampsia is blamed for about 600 and 1,000 baby deaths annually in the United Kingdom. It is estimated that one woman succumbs every six minutes due to this condition.

Researchers at St Richards Hospital in Chichester are conducting a trial to gauge the efficacy and reliability of this new test, by seeking the participation of 1000 women in the trial.

This new test, a brain child of Dr Brian Owen-Smith, a retired hospital rheumatologist, examines and monitors elevated levels of urate in the body, a possible indication of pre-eclampsia. The saliva is thought to be an overflow system for urate and is therefore a more reliable way of testing the urate levels rather than a blood or urine test.

Dr Owen-Smith said: "A salivary urate test is simple, non- invasive, quick and cheap, and can be done any time. As a metabolic test independent of blood pressure, it may obviate the need for unnecessary hospital admission."

The conventional testing that employs using blood pressure and urine monitoring is not always reliable, as the indications could be attributed to factors other than pre-eclampsia.

Michael Rich, the ch
'"/>




Page: 1 2

Related medicine news :

1. Kolkata: Landmark Health City on the Cards
2. Government Considering Of Issuing ‘Smart Cards’ For HIV/AIDS Patiens
3. Legalization of Therapeutic Abortion in UAE on the Cards
4. Legalization of Therapeutic Abortion in UAE on the Cards
5. Coca Cola To Distribute HIV/AIDS, TB, Malaria Prevention Playing Cards Among Chinese Migrant Workers
6. Cancer Cause Not Yet Ascertained
7. Risk Of Pre-eclampsia May Be In The Genes Of The Parents.
8. Pre-eclampsia Pronounced With Intake of Vitamins in Large Doses
9. Pre-eclampsia May Increase Risk Of Stroke Even After Pregnancy
10. Placental Proteins Could Be Responsible For Pre-eclampsia
Post Your Comments:
Breaking Medicine Technology:Vivakor Announces New Acquisition Strategy 2Millstone Medical Outsourcing Appoints New Leadership of Memphis Facility 2Indiana Blood Center Taps tw telecom for Data, Internet and IP Telephony Services 2PSI Commits to Expanding HIV Prevention at Clinton Global Initiative 58120 1PSI Commits to Expanding HIV Prevention at Clinton Global Initiative 58120 2PSI Commits to Expanding HIV Prevention at Clinton Global Initiative 58120 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 1Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 2Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 4Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 5Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 6Sorafenib significantly improves the length of time before breast cancer worsens 58117 1Sorafenib significantly improves the length of time before breast cancer worsens 58117 2